Charles Schwab Investment Management Inc Athenex, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.41 - $0.91 $79,375 - $176,175	-193,599 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.79 - $1.59 $21,235 - $42,740	-26,881 Reduced 12.19%	193,599 $161,000
Q4 2021 Feb 11, 2022	BUY	$1.36 - $2.94 $17,402 - $37,620	12,796 Added 6.16%	220,480 $300,000
Q3 2021 Nov 16, 2021	SELL	$2.97 - $4.84 $962,939 - $1.57 Million	-324,222 Reduced 60.95%	207,684 $626,000
Q2 2021 Aug 16, 2021	BUY	$3.71 - $5.13 $250,862 - $346,880	67,618 Added 14.56%	531,906 $2.46 Million
Q1 2021 May 17, 2021	SELL	$4.08 - $14.75 $52,884 - $191,189	-12,962 Reduced 2.72%	464,288 $2 Million
Q4 2020 Feb 16, 2021	BUY	$11.06 - $14.01 $777,949 - $985,449	70,339 Added 17.29%	477,250 $5.28 Million
Q3 2020 Nov 13, 2020	BUY	$10.26 - $14.55 $295,354 - $418,850	28,787 Added 7.61%	406,911 $4.92 Million
Q2 2020 Aug 14, 2020	BUY	$7.11 - $13.76 $218,163 - $422,211	30,684 Added 8.83%	378,124 $5.2 Million
Q1 2020 May 15, 2020	BUY	$5.71 - $15.85 $32,290 - $89,631	5,655 Added 1.65%	347,440 $2.69 Million
Q4 2019 Feb 07, 2020	BUY	$9.6 - $17.75 $187,372 - $346,444	19,518 Added 6.06%	341,785 $5.22 Million
Q3 2019 Nov 08, 2019	SELL	$12.16 - $21.0 $64,083 - $110,670	-5,270 Reduced 1.61%	322,267 $3.92 Million
Q2 2019 Aug 09, 2019	BUY	$9.44 - $19.8 $745,797 - $1.56 Million	79,004 Added 31.79%	327,537 $6.49 Million
Q1 2019 May 14, 2019	BUY	$11.11 - $13.49 $184,403 - $223,907	16,598 Added 7.16%	248,533 $3.05 Million
Q4 2018 Feb 14, 2019	SELL	$10.24 - $15.49 $30,310 - $45,850	-2,960 Reduced 1.26%	231,935 $2.94 Million
Q3 2018 Nov 13, 2018	BUY	$15.53 - $19.97 $372,813 - $479,399	24,006 Added 11.38%	234,895 $3.65 Million
Q2 2018 Aug 08, 2018	BUY	$15.88 - $19.5 $1.34 Million - $1.65 Million	84,566 Added 66.94%	210,889 $3.94 Million
Q1 2018 May 07, 2018	BUY	$13.53 - $17.47 $1.29 Million - $1.66 Million	95,048 Added 303.91%	126,323 $2.15 Million
Q4 2017 Jan 17, 2018	BUY	$14.41 - $19.15 $20,231 - $26,886	1,404 Added 4.7%	31,275 $498,000
Q3 2017 Nov 13, 2017	BUY	$13.5 - $19.51 $403,258 - $582,783	29,871	29,871 $524,000

Others Institutions Holding ATNX

# of Institutions

Shares Held

1.46M

Call Options Held

Put Options Held

Empery Asset Management, LP New York, NY

1.45M
Shares

$14,521
2.33% of portfolio
Eaton Vance Management Boston, MA

12K
Shares

$120
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Athenex, Inc.

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

More about ATNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account